STOCK TITAN

REVH - REVH STOCK NEWS

Welcome to our dedicated page for REVH news (Ticker: REVH), a resource for investors and traders seeking the latest updates and insights on REVH stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect REVH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of REVH's position in the market.

Rhea-AI Summary

Revolution Healthcare Acquisition Corp. (NASDAQ: REVH) announced plans for the redemption of all outstanding shares of its Class A Common Stock by December 2, 2022, pending stockholder approval. The redemption price is expected to be approximately $10.07 per share, based on the total balance of approximately $554 million in the Trust Account, minus dissolution expenses. Following this redemption, the company will cease operations, liquidate, and file necessary forms for delisting from NASDAQ and terminating its securities registration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags

FAQ

What is the market cap of REVH (REVH)?

The market cap of REVH (REVH) is approximately 580.1M.
REVH

Nasdaq:REVH

REVH Rankings

REVH Stock Data

580.10M
55.00M
88.46%
0.03%
Shell Companies
Financial Services
Link
United States
Cambridge